Skip to content

Sequential Determination of ED50 of Esketamine for Postoperative Analgesia in Elderly Patients undergoing Gastrointestinal Surgery

Sequential Determination of ED50 of Esketamine for Postoperative Analgesia in Elderly Patients undergoing Gastrointestinal Surgery

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091144
Enrollment
Unknown
Registered
2024-10-22
Start date
2024-10-31
Completion date
Unknown
Last updated
2024-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal cancer

Interventions

experimental group:Esketamine

Sponsors

he Second Affiliated Hosipital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients undergoing gastrointestinal tumor surgery under general anesthesia; (2) The American Society of Anesthesiologists (ASA) classifies it as Grade I~III; (3) Normal liver and kidney function, cardiopulmonary function tests suggest that the operation can be tolerated; (4) Age = 60 years old; (5) Body mass index (BMI) within the range of 18.0-30.0kg/m^2; (6) Proficient in using PCIA pumps; (7) Can understand and fully cooperate in using various postoperative scoring tools

Exclusion criteria

Exclusion criteria: (1) Combined severe cardiovascular and cerebrovascular disease; (2) Patients with poorly controlled or untreated hypertension (resting systolic/diastolic blood pressure >180/100mmHg); (3) Untreated or inadequately treated hyperthyroidism; (4) Liver and kidney dysfunction, combined with severe organ damage; (5) Consciousness disorders or severe mental or central nervous system disorders; (6) Having cognitive impairment or poor comprehension ability,and unable to communicate effectively; (7) Long term use of sedative, hypnotic, and analgesic drugs, or drug abuse; (8) Heart rate<50 beats/min or with III degree atrioventricular block; (9) Known to be allergic to experimental anesthetics; (10) Have experienced unstable angina or myocardial infarction in the past 6 months; (11) High intraocular pressure (glaucoma) or eye trauma; (12) Transfer to ICU after surgery; (13) Patient's data loss during perioperative period

Design outcomes

Primary

MeasureTime frame
Postoperative VAS score;

Secondary

MeasureTime frame
The total number of times the analgesic pump is pressed;Additional dosage if pain is still felt;Postoperative nausea and vomiting;Ramsay score;Buchholz Comfort Score;overall satisfaction;Incidence of bradycardia;Psychological adverse reactions;

Countries

China

Contacts

Public ContactLi Xiaoxia

The Second Affiliated Hosipital of Chongqing Medical University

300465@hospital.cqmu.edu.cn+86 133 6838 0465

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026